Press Releases – Current

Signant Health, the leader in evidence generation for modern clinical trials, announced today the acquisition of DSG – a leading provider of electronic data capture (EDC) and direct data capture (DDC) technology within a unified eClinical suite, for site-based and decentralized clinical trials.

DSG, Inc., a global leader of eClinical software solutions and services for the life sciences industry have incorporated Clinical Data Science (CDS) features into its eCaseLink platform Clinical Data Science (CDS) has become increasingly relevant in the eClinical industry.

DSG with 1nHealth, a global digital patient recruitment provider, are creating a seamless participant experience from the initial study launch to completion of study participation. This includes integrating pre-screened leads from 1nHealth’s secure platform into DSG’s Enrollment Tracker.

DSG works in unison with physicians to complete a full study design in a matter of days by leveraging their combined knowledge and experience to identify the most effective ways to quickly get the study up and running. The study included home-bound cancer patients.

DSG, Inc. has successfully supported their client, the Rett Syndrome Research Trust (RSRT), a non-profit organization whose mission it is to cure Rett syndrome and related MECP2 disorders by building and sharing their Rett Syndrome Global Registry database.

DSG, is applying its TeleVisit module, a key component of their decentralized trial unified platform, to uniquely solve a common clinical trial challenge and meet the FDA expectations. As the Life Sciences community adapts to decentralized trials and FDA expectations for greater adoption of eSource.

DSG, Inc., a global leader of eClinical software solutions and services for the life sciences industry has successfully collaborated with Bestat Pharmaservices Corp. (Bestat) are building studies to support COVID-19 treatments and vaccines in Asia.

DSG supports PhaseBio with unified clinical trial software

DSG, Inc., a global leader of eClinical software solutions and services for the life sciences industry has successfully launched a COVID-19 study with PhaseBio Pharmaceuticals as a treatment option.

Developing adaptive solutions for multiple Phase-3 COVID-19 trials

DSG, Inc., is supporting two Phase 3 studies sponsored by Romark, L.C. to evaluate an investigational new drug for prevention of COVID-19 in elderly residents and healthcare workers.

SeaStar Medical using eCaseLink 10 virtual technologies

DSG, Inc., a global industry leader in eClinical software and services for life sciences, harnesses its Version 10 flagship eCaseLink™ changing the game for COVID-19 rapid-start studies.

DSG’s eCaseLink 10 redefining digital source with ‘E-Source’

DSG, Inc., announced its Version 10 electronic source system integrated with its flagship unified software platforms.

Enhancing the EDC experience with an all-new eCaseLink 10

DSG, announced that it will be releasing the newest version of their flagship eCaseLink™ EDC at the heart of their unified eClinical suite of products.

DSG to attend the 54th DIA Global Annual Meeting in Boston

DSG, Inc., a industry leader in eClinical software and services to the life science industry will be exhibiting at the 54th DIA Global Annual Meeting.

DSG to attend the 17th MIXiii-BIOMED in TEL Aviv, Israel

DSG, Inc., a industry leader in eClinical software and services to the life sciences industry will be exhibiting at the 17th MIXiii-BIOMED Conference.